Home › Companies › Structuretx › Senior Director to Executive Director, Chemistry
Senior Director to Executive Director, Chemistry
Structuretx · Shanghai, Pudong District, 201203, China · Active · BambooHR
Job facts
| Field | Value |
|---|---|
| Company | Structuretx |
| Title | Senior Director to Executive Director, Chemistry |
| Normalized title | - |
| Department / team | 231- DU3 Chemistry |
| Location | Shanghai, Pudong District |
| Work model | - |
| Employment type | FTE |
| Salary | - |
| Status | active |
| ATS provider | BambooHR |
| Posted / first seen | 2026-02-09 / 2026-05-30 |
| Changed / last seen | 2026-05-30 / 2026-06-06 |
Related slices
| Page | What it contains | Open |
|---|---|---|
| Company jobs | Active postings from Structuretx. | Open |
| Company breakdowns | Role, location, ATS, and work model facets for this company. | Open |
| ATS provider jobs | Active postings observed through BambooHR. | Open |
| Provider filtered search | The same provider as a filtered job collection. | Open |
| City jobs | Active postings in Shanghai. | Open |
| Department jobs | Active postings in 231- DU3 Chemistry. | Open |
| Lifecycle events | Open, update, close, and reopen events for this posting. | Open |
| Original posting | Canonical source or apply URL captured from the ATS. | Open |
Linked records
| Company | Structuretx |
| Source | 38c0856d-8c35-49b6-a5cb-562c34852a21 |
| ATS provider | BambooHR |
Description
Job Title: Senior Director to Executive Director, Chemistry
Reports To: VP, Head of Discovery Unit 3
Location: Shanghai, China
About Us:
Structure Therapeutics develops life‐changing medicines for patients using advanced structure‐based and computational drug discovery technology. The company’s platform combines the latest advancements in visualization of molecular interactions, computational chemistry, and data integration to design orally available, superior small molecule medicines that overcome current limitations of biologic and peptide drugs. We are advancing a clinical‐stage pipeline of differentiated treatments focused on chronic diseases with high unmet need, including cardiovascular, metabolic, and pulmonary conditions.
Structure Therapeutics is led by an experienced group of international drug innovators and financed by top-tier global life sciences investors. The company completed an initial public offering (IPO) in February 2023. With offices in California and Shanghai, Structure Therapeutics has the benefit of being at the center of life science innovation in both the US and China and capitalizing on the strengths of each geographic location.
Position Summary:
This position will play a key role in advancing the research pipeline and drug discovery projects. Anchored in Discovery Unit, the successful candidate will be responsible for designing, overseeing and interpreting in vivo studies in obesity, metabolic disease and related disease areas. The position will be an essential part of an interdisciplinary team, collaborating closely with cross-functional team members and contributing to project success.
Job Responsibilities:
Scientific and Program Leadership
Provide medicinal chemistry leadership for one or more discovery programs, guiding design strategy from hit identification through lead optimization and candidate selection.
Define and drive compound design hypotheses integrating structure–activity relationships (SAR), structure-based drug design, physicochemical properties, and developability.
Partner with DMPK/ADME, in vitro/in vivo pharmacology, safety, and translational teams to optimize potency, selectivity, PK/PD, and overall drug-like profiles.
Lead scientific decision-making at program milestones; present clear, data-driven recommendations to governance and senior leadership.
Team and Organizational Leadership
Build, lead, and mentor a medicinal chemistry team (internal scientists and external partners), fostering a collaborative, high-accountability culture.
Set clear goals and development plans for direct reports; recruit and retain top talent as the organization grows.
Establish best practices for design cycles, data review cadence, documentation, and knowledge sharing.
Externalization and Partner Management
Manage CRO/CMO medicinal chemistry activities: scope definition, compound plan development, quality control, timelines, and budgets.
Ensure effective communication across time zones; maintain high scientific rigor and reproducibility across external work.
Cross-Functional Collaboration
Work closely with Structural Biology, Computational Chemistry, and Informatics to accelerate design-make-test-analyze (DMTA) cycles.
Collaborate with CMC and Pharmaceutical Sciences to transition candidates and address synthetic feasibility, scalability, salt forms, and impurity risks.
Contribute to IP strategy with legal/IP counsel: invention disclosures, patent support, and competitive landscaping.
Operational Excellence
Drive program execution with strong planning, risk management, and prioritization.
Ensure high-quality experimental design, data integrity, and clear reporting aligned with company standards
Qualifications:
Deliver repeatable DC output across modalities
PhD in Organic Chemistry, Medicinal Chemistry, or related discipline with 12+ years of relevant industry experience (or MS with additional industry experience).
Demonstrated track record of advancing small-molecule programs through lead optimization to candidate selection (ideally multiple programs).
Proven ability to lead cross-functional discovery teams and influence program strategy at the portfolio level.
Deep expertise in SAR development, property optimization (e.g., potency/selectivity/solubility/permeability/metabolic stability), and developability considerations.
Strong understanding of DMPK concepts and how to integrate ADME/PK data into compound design decisions.
Experience managing external partners (CROs) including scientific oversight, timelines, and budgets.
Excellent communication skills with ability to present complex data clearly to technical and non-technical stakeholders.
Full job record
| Job ID | be3b56fd484ed96581d4e060de2eac8a1f4b33b9 |
| Org ID | b5f128c7-6a59-48ec-b4a1-123352a40cd1 |
| Source ID | 38c0856d-8c35-49b6-a5cb-562c34852a21 |
| Board ID | 38c0856d-8c35-49b6-a5cb-562c34852a21 |
| Provider | bamboohr |
| Provider Job Key | 356 |
| Title | Senior Director to Executive Director, Chemistry |
| Normalized Title | — |
| Status | active |
| Active | yes |
| Location Text | Shanghai, Pudong District, 201203, China |
| Department | 231- DU3 Chemistry |
| Team | — |
| Employment Type | FTE |
| Workplace Type | — |
| Remote Policy | — |
| Country | — |
| Region | Pudong District |
| City | Shanghai |
| Salary Raw | — |
| Salary Min | — |
| Salary Max | — |
| Salary Currency | — |
| Salary Period | — |
| Source URL | https://structuretx.bamboohr.com/careers/356 |
| Apply URL | https://structuretx.bamboohr.com/careers/356 |
| First Seen At | 2026-05-30 05:46:19Z |
| Last Seen At | 2026-06-06 10:25:15Z |
| Last Checked At | 2026-06-06 10:25:15Z |
| Last Changed At | 2026-05-30 05:46:19Z |
| Inactive At | — |
| Source Posted At | 2026-02-09 00:00:00Z |
| Source Updated At | — |
| Raw Payload Uri | s3://job-postings-prod-raw-590183727216/raw/provider=bamboohr/board=structuretx/date=2026-06-06/2026-06-06T10-25-11-232Z-9b87bbdde4762962051cb95d1b4dc317bf40628eadc6ec356d1a3f3dac1039ae.json |
Event Fields
{
"content_hash": "e0c9ba86210d58edc524d4e4a6fc6dff1d49e9c3d2218ed780ba884a96e180b0",
"source_hash": "43fd78e4fa6e584ae3900815008b2fbeebcb7a40dccf64cf2488f42fff1ffbe2",
"last_changed_at": "2026-05-30T05:46:19.051Z",
"active_status": "active"
}Parsed Structured
{
"language": "en",
"location": {
"raw": "Shanghai, Pudong District, 201203, China",
"city": "Shanghai",
"region": "Pudong District",
"country": null,
"is_remote": false,
"confidence": 0.8
},
"salary_max": null,
"salary_min": null,
"inferred_at": "2026-06-06T10:25:15.449Z",
"launch_scope": {
"reason": "bamboohr_production_catalog",
"included": true,
"location": {
"raw": "Shanghai, Pudong District, 201203, China",
"city": "Shanghai",
"region": "Pudong District",
"country": null,
"is_remote": false,
"confidence": 0.8
},
"countries": []
},
"remote_policy": null,
"salary_period": null,
"workplace_type": null,
"salary_currency": null
}Extensions
{}Native Structured
{
"list_job": {
"id": "356",
"isRemote": null,
"location": {
"city": "Shanghai",
"state": "Pudong District"
},
"atsLocation": {
"city": null,
"state": null,
"country": null,
"province": null
},
"departmentId": "19485",
"locationType": "0",
"jobOpeningName": "Senior Director to Executive Director, Chemistry",
"departmentLabel": "231- DU3 Chemistry",
"employmentStatusLabel": "FTE"
},
"detail_errors": [],
"detail_job_opening": {
"location": {
"city": "Shanghai",
"state": "Pudong District",
"postalCode": "201203",
"addressCountry": "China"
},
"datePosted": "2026-02-09",
"atsLocation": {
"city": null,
"state": null,
"country": null,
"countryId": null
},
"description": "<p><span style=\"font-weight: bold\">Job Title:</span><span style=\"font-weight: bold\"> Senior Director to Executive Director, Chemistry</span><br></p>\n<p><span style=\"font-weight: bold\">Reports To:</span><span style=\"font-weight: bold\"> VP, Head of Discovery Unit 3</span></p>\n<p><span style=\"font-weight: bold\">Location:</span> <span style=\"font-weight: bold\">Shanghai, China</span></p>\n<p><br><br></p>\n<p><span style=\"font-weight: bold\">About Us:</span></p>\n<p>Structure Therapeutics develops life‐changing medicines for patients using advanced structure‐based and computational drug discovery technology. The company’s platform combines the latest advancements in visualization of molecular interactions, computational chemistry, and data integration to design orally available, superior small molecule medicines that overcome current limitations of biologic and peptide drugs. We are advancing a clinical‐stage pipeline of differentiated treatments focused on chronic diseases with high unmet need, including cardiovascular, metabolic, and pulmonary conditions.</p>\n<p>Structure Therapeutics is led by an experienced group of international drug innovators and financed by top-tier global life sciences investors. The company completed an initial public offering (IPO) in February 2023. With offices in California and Shanghai, Structure Therapeutics has the benefit of being at the center of life science innovation in both the US and China and capitalizing on the strengths of each geographic location.</p>\n<p> </p>\n<p><span style=\"font-weight: bold\">Position Summary:</span></p>\n<p>This position will play a key role in advancing the research pipeline and drug discovery projects. Anchored in Discovery Unit, the successful candidate will be responsible for designing, overseeing and interpreting in vivo studies in obesity, metabolic disease and related disease areas. The position will be an essential part of an interdisciplinary team, collaborating closely with cross-functional team members and contributing to project success. </p>\n<p><br><br></p>\n<p><span style=\"font-weight: bold\">Job Responsibilities: </span></p>\n<p><span style=\"font-weight: bold\">Scientific and Program Leadership</span></p>\n<ul>\n<li>Provide medicinal chemistry leadership for one or more discovery programs, guiding design strategy from hit identification through lead optimization and candidate selection.</li>\n<li>Define and drive compound design hypotheses integrating structure–activity relationships (SAR), structure-based drug design, physicochemical properties, and developability.</li>\n<li>Partner with DMPK/ADME, in vitro/in vivo pharmacology, safety, and translational teams to optimize potency, selectivity, PK/PD, and overall drug-like profiles.</li>\n<li>Lead scientific decision-making at program milestones; present clear, data-driven recommendations to governance and senior leadership.</li>\n</ul>\n<p><span style=\"font-weight: bold\">Team and Organizational Leadership</span></p>\n<ul>\n<li>Build, lead, and mentor a medicinal chemistry team (internal scientists and external partners), fostering a collaborative, high-accountability culture.</li>\n<li>Set clear goals and development plans for direct reports; recruit and retain top talent as the organization grows.</li>\n<li>Establish best practices for design cycles, data review cadence, documentation, and knowledge sharing.</li>\n</ul>\n<p><span style=\"font-weight: bold\">Externalization and Partner Management</span></p>\n<ul>\n<li>Manage CRO/CMO medicinal chemistry activities: scope definition, compound plan development, quality control, timelines, and budgets.</li>\n<li>Ensure effective communication across time zones; maintain high scientific rigor and reproducibility across external work.</li>\n</ul>\n<p><span style=\"font-weight: bold\">Cross-Functional Collaboration</span></p>\n<ul>\n<li>Work closely with Structural Biology, Computational Chemistry, and Informatics to accelerate design-make-test-analyze (DMTA) cycles.</li>\n<li>Collaborate with CMC and Pharmaceutical Sciences to transition candidates and address synthetic feasibility, scalability, salt forms, and impurity risks.</li>\n<li>Contribute to IP strategy with legal/IP counsel: invention disclosures, patent support, and competitive landscaping.</li>\n</ul>\n<p> </p>\n<p><span style=\"font-weight: bold\">Operational Excellence</span></p>\n<ul>\n<li>Drive program execution with strong planning, risk management, and prioritization.</li>\n<li>Ensure high-quality experimental design, data integrity, and clear reporting aligned with company standards</li>\n</ul>\n<p> </p>\n<p><span style=\"font-weight: bold\">Qualifications: </span></p>\n<ul>\n<li>Deliver repeatable DC output across modalities</li>\n<li>PhD in Organic Chemistry, Medicinal Chemistry, or related discipline with 12+ years of relevant industry experience (or MS with additional industry experience).</li>\n<li>Demonstrated track record of advancing small-molecule programs through lead optimization to candidate selection (ideally multiple programs).</li>\n<li>Proven ability to lead cross-functional discovery teams and influence program strategy at the portfolio level.</li>\n<li>Deep expertise in SAR development, property optimization (e.g., potency/selectivity/solubility/permeability/metabolic stability), and developability considerations.</li>\n<li>Strong understanding of DMPK concepts and how to integrate ADME/PK data into compound design decisions.</li>\n<li>Experience managing external partners (CROs) including scientific oversight, timelines, and budgets.</li>\n<li>Excellent communication skills with ability to present complex data clearly to technical and non-technical stakeholders.</li>\n</ul>\n<p> </p>",
"compensation": null,
"departmentId": "19485",
"locationType": "0",
"seekPromoted": false,
"jobCategoryId": null,
"jobOpeningName": "Senior Director to Executive Director, Chemistry",
"departmentLabel": "231- DU3 Chemistry",
"jobOpeningStatus": "Open",
"minimumExperience": "Experienced",
"jobOpeningShareUrl": "https://structuretx.bamboohr.com/careers/356",
"employmentStatusLabel": "FTE"
}
}Get this page with API
Rendered from the bluedoor Job Postings API. Reproduce it:
GET https://api.bluedoor.sh/job-postings/v1/jobs/be3b56fd484ed96581d4e060de2eac8a1f4b33b9?include=descriptionJSONGET https://api.bluedoor.sh/job-postings/v1/orgs/b5f128c7-6a59-48ec-b4a1-123352a40cd1JSONGET https://api.bluedoor.sh/job-postings/v1/sources/38c0856d-8c35-49b6-a5cb-562c34852a21JSONGET https://api.bluedoor.sh/job-postings/v1/jobs/be3b56fd484ed96581d4e060de2eac8a1f4b33b9/eventsJSON